statistiche ricercatore

Continente	#
NA - Nord America	818
AS - Asia	374
EU - Europa	267
SA - Sud America	53
AF - Africa	24
Continente sconosciuto - Info sul continente non disponibili	10
OC - Oceania	2
Totale	1.548

Nazione	#
US - Stati Uniti d'America	778
SG - Singapore	153
IT - Italia	96
CN - Cina	74
VN - Vietnam	57
BR - Brasile	40
DE - Germania	32
HK - Hong Kong	31
FR - Francia	26
SE - Svezia	25
UA - Ucraina	23
CA - Canada	22
BD - Bangladesh	19
TR - Turchia	18
IE - Irlanda	13
MX - Messico	12
GB - Regno Unito	11
MA - Marocco	10
RU - Federazione Russa	9
ES - Italia	8
FI - Finlandia	8
IN - India	7
TN - Tunisia	5
AR - Argentina	4
AT - Austria	4
ZA - Sudafrica	4
LT - Lituania	3
NG - Nigeria	3
NL - Olanda	3
PK - Pakistan	3
VE - Venezuela	3
EC - Ecuador	2
ID - Indonesia	2
JM - Giamaica	2
PL - Polonia	2
PY - Paraguay	2
SA - Arabia Saudita	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AU - Australia	1
BB - Barbados	1
BE - Belgio	1
BO - Bolivia	1
CL - Cile	1
CR - Costa Rica	1
DZ - Algeria	1
EG - Egitto	1
GD - Grenada	1
IQ - Iraq	1
JO - Giordania	1
JP - Giappone	1
LK - Sri Lanka	1
MD - Moldavia	1
NP - Nepal	1
PH - Filippine	1
PW - Palau	1
SK - Slovacchia (Repubblica Slovacca)	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
Totale	1.538

Nome	#
Up-regulation and stabilization of HIF-1α in colorectal carcinomas	262
Somatic Testing on Gynecological Cancers Improve the Identification of Lynch Syndrome	242
Localization of carboxyl ester lipase in human pituitary gland and pituitary adenomas	207
Mixed Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) of the Ovary Arising from Endometriosis: Molecular Pathology Analysis in Support of a Pathogenetic Paradigm	152
From therapy to cancer prevention using HRD testing on high grade ovarian cancer patients	98
Strategies for Lynch syndrome identification in selected and unselected gynecological cancers	97
Case Report: Male Lobular Breast Cancer in Hereditary Cancer Syndromes	87
BRCA methylation testing identifies a subset of ovarian carcinomas without germline variants that can benefit from PARP inhibitor	87
HPV nonrelated endocervical adenocarcinoma in hereditary cancer syndromes	85
OncoPan®: An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma	84
PALB2 analysis in the diagnostic process of breast cancer: an Italian monocentric experience	72
Similarities and differences in gene expression profiles of BRCA1 methylated and mutated epithelial ovarian cancers	63
From Molecular Classification to Hereditary Cancer Syndrome Identification in Endometrial Cancer	12
Totale	1.548

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	35	0	0	0	0	2	4	3	4	9	4	4	5
2022/2023	121	4	2	9	11	12	24	0	29	21	3	5	1
2023/2024	115	16	14	9	16	14	19	1	3	12	5	2	4
2024/2025	225	1	5	35	13	9	11	7	9	37	36	17	45
2025/2026	609	55	42	33	90	59	39	103	47	49	41	24	27
2026/2027	100	8	21	54	17	0	0	0	0	0	0	0	0
Totale													1.548